14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.073 22 days ( -16.08 % )
Last Price HK$16.60 -0.599 %
High/ Low HK$16.18 - HK$16.98 6.67%
Chg 7 Days 0.606 % $16.50 HK$16.60
Chg 30 Days 17.40 % $14.14 HK$16.60
Chg 12 mos 22.78 % $13.52 HK$16.60
Trend - 3 mos 23.69 % Width: 14.12 %
Trend - 12 mos 24.83 % Width: 50.39 %
Pred. range - 3 mos HK$18.37 - HK$20.96 10.66 % - 26.28 %
Pred. range - 12 mos HK$14.59 - HK$21.94 -12.11 % - 32.18 %
Short MA avg 3 mos Buy Apr 18, 2024 - 11 days
Long MA avg 3 mos Sell Mar 27, 2024 - 24 days
Short/Long MA avg 3 mos Buy Mar 05, 2024 - 40 days
Short MA avg 12 mos Buy Mar 28, 2024 - 23 days
Long MA avg 12 mos Sell Mar 27, 2024 - 24 days
Short/Long MA avg 12 mos Buy Mar 12, 2024 - 35 days
Pivot Short Sell Apr 29, 2024 - 4 days
Bollinger Buy May 02, 2024 - 2 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Shanghai Henlius Biotech Inc

Shanghai Henlius Biotech Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating non-hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis; HANQUYOU, a trastuzumab injection to treat breast and metastatic gastric cancer; HANDAYUAN, an adalimumab injection for t... 2696.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT